1. Volume 4, Pages 193-197 (September 2014)
Elevated urinary albumin excretion complements the Framingham Risk Score for the prediction of cardiovascular risk — response to treatment in the PREVEND IT trial 
Frank P. Brouwers, Folkert W. Asselbergs, Hans L. Hillege, Ron T. Gansevoort, Rudolf A. de Boer, Wiek H. van Gilst 
IJC Heart & Vessels 
Volume 4, Pages (September 2014)
DOI: /j.ijchv
Copyright © Terms and Conditions

2. Fig. 1
Median urinary albumin excretion (mg/24 h) by treatment and visit. Triangles refer to placebo group and circles refer to treatment group (fosinopril).
IJC Heart & Vessels 2014 4, DOI: ( /j.ijchv )
Copyright © Terms and Conditions

3. Fig. 2
A and B. Predicted Framingham Risk Score compared to Kaplan–Meier estimates of incidence of cardiovascular events in fosinopril and placebo group, divided by a UAE < 50 mg/24 h and UAE ≥ 50 mg/24 h.
IJC Heart & Vessels 2014 4, DOI: ( /j.ijchv )
Copyright © Terms and Conditions